Диссертация (1139494), страница 36
Текст из файла (страница 36)
- 2010.116. http://spid-vich.info/gepatity. [В Интернете]117. Кравченко А.В. www.mosmedclinic.ru, 2012. [В Интернете]118. Gendelman. Trans-activation of the human immunodeficiency virus long terminalrepeat sequence by DNA viruses. // Proceedings of the National Academy of Sciences. 1986. - №83 (24).119. Гепатиты В и С на фоне ВИЧ-инфекции, диагностика, особенности лечения.ВИЧ-инфекция и гепатиты. [В Интернете] http://spid-vich.info/gepatity-v-i-s-nafone-vich-infekcii-diagnostika-osobennosti-lecheniya.120.
Gendelman, H.E. et al. Trans-activation of the human immunodeficiency viruslong terminal repeat sequence by DNA viruses. // PNAS. - 1986. - №83 (24). - P.9759–9763.121. webground.su.rubric, 2009. [В Интернете]122. vmede.org/sait.02.12.15. [В Интернете]123. immunologia.ru/hepatitis.html.
[В Интернете]124. Marmor M. Resistance to HIV infection / Marmor M., Hertzmark K., Thomas S.M.et al. // J Urban Health. - 2006. - №83 (1). - Р. 5-17.125. Naif H.M. Pathogenesis of HIV Infection/ Naif H.M. // Infect Dis Rep. - Jun 6. 2013. - №5 (Suppl 1).126. Alvarez V., López-Larrea C., Coto E. Mutational analysis of the CCR5 andCXCR4 genes (HIV-1 co-receptors) in resistance to HIV-1 infection and AIDSdevelopment among intravenous drug users/Alvarez V., López-Larrea C., Coto E.//Hum Genet.
- 1998. №102 (4), P. 483-486.127. Guergnon J., Combadière C. Role of chemokines polymorphisms in diseases. //Immunol Lett. - 2012. - №145 (1-2). Р. 15-22.128. Poropatich K. Human immunodeficiency virus type 1 long-term non-progressors:the viral, genetic and immunological basis for disease non-progression / Poropatich K.,Sullivan DJ Jr. // J Gen Virol.
- 2011. - Feb. - № 92 (Pt 2). - Р. 247-268.129. O’Brien S.J., Moore J.P. The effect of genetic variation in chemokines and theirreceptors on HIV transmission and progression to AIDS/ O’Brien S.J., Moore J.P. //Immunol Rev. - 2000. - №177. - Р. 99-111.226130. Tang J. Favorable and unfavorable HLA class I alleles and haplotypes in Zambianspredominantly infected with clade C human immunodeficiency virus type 1 / Tang J.,Tang S., Lobashevsky E. et al. // J Virol.
- 2002. - № 76 (16). Р. 8276-8284.131. Altfeld M. Influence of HLA-B57 on clinical presentation and viral control duringacute HIV-1 infection./Altfeld M., Addo M., Rosenberg E. et al. //AIDS.- 2003. №17.Р.2581-2591.132. Tang J. The impact of host genetics on HIV infection and disease progression inthe era of highly active antiretroviral therapy/ Tang J., Kaslow R. // AIDS. - 2003. - 17(Suppl 1), S51-S60.133.
Stephens H.A. Immunogenetic surveillance of HIV/ AIDS / Stephens H.A. // InfectGenet Evol. - 2012. - Oct. - №12(7). - Р.1481-1491. - Epub 2012 May 7. An P1.134. Winkler C.A. Host genes associated with HIV/AIDS: advances in gene discovery/Winkler C.A. // Trends Genet. - 2010. - Mar. - № 26(3). - Р. 119-31. - Epub 2010 Feb10.135. Martin M.P. Epistatic interaction between KIR3DS1 and HLA-B delays theprogression to AIDS/ Martin M.P., Gao X., Lee J-H et al. // Nat Genet.
- 2002. - № 31,Р. 429–434.136. Middleton D. Killer immunoglobulin receptor gene and allele frequencies inCaucasoid, Oriental and Black populations from different continents/ Middleton D,Meenagh A, Moscoso J, Arnaiz-Villena A. // Tissue Antigens. - 2008. - №71 (2). - Р.105-113.137. Shin H.D. Genetic restriction of HIV-1 pathogenesis to AIDS by promoter allelesof IL10 / Shin H.D., Winkler C., Stephens J.C.
et al. // Proc Natl Acad Sci USA. - 2000.- № 97 (26), - Р. 14467-14472.138. Price P. Alleles of the gene encoding IL-1alpha may predict control of plasmaviraemia in HIV-1 patients on highly active antiretroviral therapy/ Price P., James I.,Fernandez S., French M.A. // AIDS. - 2004. - №18 (11). - Р. 1495-1501.139. Ball T.B. Polymorphisms in IRF-1 associated with resistance to HIV-1 infection inhighly exposed uninfected Kenyan sex workers/Ball T.B., Ji H., Kimani J. et al. //AIDS. - 2007.
- №21 (9). - Р.1091-1101.140. Akihiko S. Spector Effect of Host Genetic Variation on the Pharmacokinetics andClinical Response of Non-nucleoside Reverse Transcriptase Inhibitors/Akihiko S.,Stephen A. //Futur HIV Therapy.- 2008. -№ 1. - P. 69–81.141. Brown K.C. Exploration of CYP450 and drug transporter genotypes andcorrelations with nevirapine exposure in Malawians/ Brown K.C., Hosseinipour M.C.,Hoskins J.M.
Et al. // Pharmacogenomics. - 2012. - № 1. - P.113-121.142. Heil S.G. Associations between ABCB1, CYP2A6, CYP2B6, CYP2D6, andCYP3A5 alleles in relation to efavirenz and nevirapine pharmacokinetics in HIV-227infected individuals/ Heil S.G., van der Ende M.E., Schenk P.W. et al. // Ther DrugMonit. - 2012. - Vol. 34, № 2. - P.123.143. Sánchez, Tozzi, Wang. Pharmacogenomics of drug-metabolizing enzymes: arecent update on clinical implications and endogenous effects. - 2012. (www.nature.com/tpj/journal/v13/n1/full/tpj201245a.html) 23 Oct. [В Интернете]144. Tozzi V.
Pharmacogenetics of antiretrovirals / Tozzi V. // Antiviral Res. - 2010. Vol. 85, № 1. - P. 190-200.145. Sánchez H.V. Toxicogenetics of antiretroviral treatment (II): neurotoxicity,hepatotoxicity, lactic acidosis, kidney damage, and other adverse effects ofantiretroviral drugs/ Sánchez H.V., Gutiérrez R.F. // Enferm Infecc Microbiol Clin. 2008. - Vol. 26, № 6.
- P. 2.146. Канестри В.Г. Безопасность и переносимость современных схемантиретровирусной терапии у взрослых больных ВИЧ-инфекцией. автореф. канд.мед. наук / В.Г. Канестри. - М.: 2014. - 48 с.147. Консультирование как способ повышения приверженности к лечениюинфицированных ВИЧ пациентов/ Саламов Г.Г. , Бобкова М.Р., Беляева В.В.//Инфекционные болезни. - 2012.
- Т. 10, № 3. - С. 75-79. Г.Г., Саламов.148. Канестри В.Г. автореферат. 2015.149. Nolan D. Tumour necrosis factor-α gene-238G/A promoter polymorphismassociated with a more rapid onset of lipodystrophy/Nolan D., Moore C., Castley A. etal. // AIDS. - 2003. - Vol. 17. – P. 121–123.150. Alfirevic Ana.
Drug induced hypersensitivity and the HLA complex/Alfirevic,Huang, Sánchez, Tozzi, Wang, Alfirevic A., Pirmohamed M. //Pharmaceuticals.- 2011.Vol. 4. – P. 69-90.151. Huang X., Ling H., Mao W., Ding X. et al. Human leukocyte antigen profile inHIV-1 infected individuals and AIDS patients from Chongqing, China/ Huang X., LingH., Mao W., Ding X. et al. // Microbiol. Immunol. – 2009.
- № 9. – Vol. 53. – P. 512523.152. Wang L. Genomics and Drug Response / Wang L., Mc Leod H.L. et al. // N. Engl.J. Med. – 2011. – Vol. 364. – P. 1144-1153.153. Asensi V. IL-1beta (+3954C/T) polymorphism could protect humanimmunodeficiency virus (HIV)-infected patients on highly active antiretroviraltreatment (HAART) against lipodystrophic syndrome/Asensi V., Rego C., Montes A.H.,Collazos J. et al. // Genet Med. - 2008. Р.
120-123.154. Silva M.M. TNF microsatellite alleles may confer protection against thedevelopment of lipodystrophy syndrome in Brazilian HIV patients/ Silva M.M., SimõesR.T., Castelli E.C. et al. // Int J Immunogenet. - 2010. - Vol. 37. - № 5. - P. 379-385.228155. Castelar L. Interleukin-18 and interferon-gamma polymorphisms in Brazilianhuman immunodeficiency virus-1-infected patients presenting with lipodystrophysyndrome/Castelar L., Silva M.M., Castelli E.C. et al. // Tissue Antigens. - 2010. - Vol.76, № 2.
- P. 126-136.156. Bonnet E. Association of APOC3 polymorphisms with both dyslipidemia andlipoatrophy in HAART-receiving patients/ Bonnet E., Bernard J., Fauvel J. et al. //AIDS Res Hum Retroviruses. - 2008. - № 2. - P. 169-171.157. Chiappini F. Relationship between polymerase gamma (POLG) polymorphismsand antiretroviral therapy-induced lipodystrophy in HIV-1 infected patients: a casecontrol study/ Chiappini F., Teicher E., Saffroy R.
et al. // Curr HIV Res. - 2009. - № 2.- P. 244-253.158. Kallianpur A. R. Hemochromatosis (HFE) gene mutations and peripheralneuropathy during antiretroviral therapy/ Kallianpur A. R., Hulgan, T., Canter, J. A., etal. // AIDS. - 2006. - Vol.20. - N.11. - Р. 1503-13.159. Marzocchetti A. The effect of polymorphisms in candidate genes on the long-termrisk of lipodystrophy and dyslipidemia in HIV-infected white patients startingantiretroviral therapy/ Marzocchetti A., Schwarz J., Di Giambenedetto S. et al.
// AIDSRes Hum Retroviruses. - 2011.160. Zanone P.B. Genetic polymorphisms differently influencing the emergence ofatrophy and fat accumulation in HIV-related lipodystrophy / Zanone P.B., Riva A., NasiM. et al. // AIDS. - 2008. - Vol. 22. - №14. - P. 1769-1778.161. Anderson K.S. A transient kinetic approach to investigate nucleoside inhibitors ofmitochondrial DNA polymerase gamma/Anderson K.S. // Methods. - 2010. - Vol. 51,№ 4.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
